Johann S. Hawe

ORCID: 0000-0003-3890-303X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epigenetics and DNA Methylation
  • Bioinformatics and Genomic Networks
  • Genetic Associations and Epidemiology
  • Alzheimer's disease research and treatments
  • Cholesterol and Lipid Metabolism
  • Adipose Tissue and Metabolism
  • Cancer-related molecular mechanisms research
  • MicroRNA in disease regulation
  • Venous Thromboembolism Diagnosis and Management
  • Acute Myocardial Infarction Research
  • Amyotrophic Lateral Sclerosis Research
  • Nuclear Receptors and Signaling
  • Gene expression and cancer classification
  • Computational Drug Discovery Methods
  • Machine Learning in Healthcare
  • Gene Regulatory Network Analysis
  • Birth, Development, and Health
  • Artificial Intelligence in Healthcare and Education
  • Health Systems, Economic Evaluations, Quality of Life
  • Circadian rhythm and melatonin
  • Advanced X-ray and CT Imaging
  • Lipoproteins and Cardiovascular Health
  • Circular RNAs in diseases
  • Genetic Syndromes and Imprinting
  • CRISPR and Genetic Engineering

Technical University of Munich
2019-2023

Deutsches Herzzentrum München
2021-2023

Helmholtz Zentrum München
2019-2022

Ludwig-Maximilians-Universität München
2014

10.1038/s41588-021-00969-x article EN Nature Genetics 2022-01-01

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Non-coding RNAs have already been linked to CVD development progression. While microRNAs (miRs) well studied in blood samples, there little data on tissue-specific miRs cardiovascular relevant tissues their relation risk factors. Tissue-specific derived from Arteria mammaria interna (IMA) 192 coronary artery (CAD) patients undergoing bypass grafting (CABG) were analyzed. The aims study 1) establish a...

10.3390/biom11111683 article EN cc-by Biomolecules 2021-11-12

Machine learning (ML) approaches have the potential to uncover regular patterns in multi-layered data. Here we applied self-organizing maps (SOMs) detect such with aim better predict in-stent restenosis (ISR) at surveillance angiography 6 8 months after percutaneous coronary intervention stenting.

10.3390/jcm12082941 article EN Journal of Clinical Medicine 2023-04-18
Nils Krüger Johannes Krefting Thorsten Kessler Raphael Schmieder Fabian Starnecker and 95 more Alexander Dutsch Christian Graesser Ulrike Meyer-Lindemann T Storz Irina Pugach Christian Frieß Zhifen Chen Dario Bongiovanni I. Manea Tobias Dreischulte Frank Offenborn P Krase Hendrik B. Sager Jens Wiebe Sebastian Kufner Erion Xhepa Michael Joner Teresa Trenkwalder Ulrich Gueldener Adnan Kastrati Salvatore Cassese Heribert Schunkert Moritz von Scheidt Jonathan Adam Reiner Anselm Sara Ates Sabine Bauer Nicole Beck J. Beckmann Riccardo Berutti Stefan Brandmaier T.S. Bruun Salvatore Cassese Manuela Decker Martin Dichgans Philine Diesselhorst H Domdey S. Doppler Martina Dreßen Arne Dressler Florent Dufour Sven Duscha Hans‐Henning Eckstein Aiman Farzeen Therese Feiler Christian Frieß I. Gall Ulrich M. Gassner Christian Gieger Monica Gotor-Blazquez Ulrich Gueldener Nicolay Hammer Johann S. Hawe Verena Heidel Thomas Hendel Stefan Holdenrieder Stephan Jonas M. Kameric Adnan Kastrati Thorsten Kessler Katharina Knoedlseder Wolfgang Köenig Florian Kohlmayer Markus Krane Dieter Kranzelmueller Johannes Krefting Nils Krüger Anja Kroke Harald Lahm Rüediger Lange Andreas Lehmann Ling Li Birgit Linkohr Lars Mäegdefessel Matthias Mann Rainer Malik Thomas Meitinger Irina Neb T O'Hehir Shichao Pang Benedikt Perl Annette Peters Fatemeh Peymani R. Pichler Heiko Pfister Paola Pisano Holger Prokisch Irina Pugach Lara Marie Reimer Michaela Sander Veronika Sanin Lea D. Schlieben Yannick Schlote Sofie Schmid Raphael Schmieder

Importance In patients with acute coronary syndrome (ACS) undergoing invasive treatment, ticagrelor and prasugrel are guideline-recommended P2Y12 receptor inhibitors. The ISAR-REACT5 randomized clinical trial demonstrated superiority for prasugrel, although concerns were raised about the generalizability of some underpowered subgroup analyses. Objectives To emulate a evaluating safety effectiveness vs under conditions routine care in individuals ACS planned to undergo an treatment strategy....

10.1001/jamanetworkopen.2024.48389 article EN cc-by-nc-nd JAMA Network Open 2024-12-02

Molecular measurements of the genome, transcriptome, and epigenome, often termed multi-omics data, provide an in-depth view on biological systems their integration is crucial for gaining insights in complex regulatory processes. These data can be used to explain disease related genetic variants by linking them intermediate molecular traits (quantitative trait loci, QTL). networks regulating cellular processes leave footprints QTL results as so-called trans-QTL hotspots. Reconstructing these...

10.1186/s13073-022-01124-9 article EN cc-by Genome Medicine 2022-11-07

Coronary artery disease (CAD) is a complex, multifactorial caused, in particular, by inflammation and cholesterol metabolism. At the molecular level, role of tissue-specific signaling pathways leading to CAD still largely unexplored. This study relied on two main resources: (1) genes with impact atherosclerosis/CAD, (2) liver-specific transcriptome analyses from human mouse studies. The transcription factor activating 3 (ATF3) was identified as key regulator liver network relevant...

10.3390/metabo12090840 article EN cc-by Metabolites 2022-09-06

Abstract Background Molecular multi-omics data provide an in-depth view on biological systems, and their integration is crucial to gain insights in complex regulatory processes. These can be used explain disease related genetic variants by linking them intermediate molecular traits (quantitative trait loci, QTL). networks regulating cellular processes leave footprints QTL results as so-called trans -QTL hotspots. Reconstructing these a endeavor use of prior information has been proposed...

10.1101/2020.05.19.101592 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-05-21
Coming Soon ...